Stories Around the Globe

China Okays Trials for COVID-19 First Nasal Spray Vaccine

China has approved for human trial, the first nasal spray vaccine against the coronavirus that has claimed over 904,000 lives globally. The nasal spray vaccine is expected to start phase 1 clinical trials in November.        

According to Global Times, it is the only vaccine of its type that has gained approval by the China’s National Medical Products Administration. 

A Beijing-based Immunologist revealed that compared with injections, a nasal spray vaccine is easier to administer and would also be easy to mass-produce, and distribute as it adopts the mature influenza vaccine production technology.     

Leave a Reply

Your email address will not be published.